TY - JOUR PY - 2012 J2 - Biochem. Biophys. Res. Commun. SN - 0006-291X T2 - Biochemical and Biophysical Research Communications VL - 427 IS - 3 DO - 10.1016/j.bbrc.2012.09.114 TI - Targeting ILK and beta 4 integrin abrogates the invasive potential of ovarian cancer UR - https://www.cheric.org/research/tech/periodicals/view.php?seq=1069138 KW - Ovarian cancer KW - ILK (integrin-linked kinase) KW - beta 4 Integrin KW - Combined effect KW - Invasiveness AU - Choi YP AU - Kim BG AU - Gao MQ AU - Kang S AU - Cho NH SP - 642 EP - 648 LA - English ER -